People who are undergoing dialysis and have anemia caused by chronic kidney disease may receive a monthly injection of Omontys. This prescription drug is given through an intravenous (IV) infusion or as an injection just under the skin. It is given once a month and is approved for use in adults only. Side effects may include diarrhea, nausea, and shortness of breath.
In February 2013, Omontys was pulled from the market (all of the product was recalled) to investigate reports of dangerous allergic reactions, including fatal anaphylactic reactions, which appear to be occurring more frequently than anticipated. This medication will not be available until further notice.